Status:
UNKNOWN
Modelling Internal Hepatic Movement With an External Abdominal Marker
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Conditions:
Patients With Liver Metastases From Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study tests the feasibility and reproducibility of patient-specific motion models. These will be used for quantification of safe margin reduction. Patient-specific motion models will be built by ...
Detailed Description
The study will use a real time position management (RPM) system for respiratory gating. The RPM system senses the respiration motion of the patient by tracking a pair of reflective markers on a lightw...
Eligibility Criteria
Inclusion
- Histologically confirmed adenocarcinoma compatible with primary disease in the colon or rectum
- Aged 18 years or older
- Unequivocal contrast-enhanced CT and/or MRI evidence of malignant single or multiple metastases in the liver, metastases at other sites will not be an exclusion criterion
- WHO performance status 0-2 and life expectancy of at least 12 weeks
- Informed written consent
Exclusion
- Pregnancy or breast feeding
- Evidence of ascites
- Patients unable for whatever reason to lie flat
- Patients unable to give fully informed consent
- Age\< 18 years
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00299299
Start Date
June 1 2006
Last Update
January 12 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Marsden Hospital
Chelsea, United Kingdom